As of June 12, 2025, Psychemedics Corp (PMD) reports a Net Margin of -18.80%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Psychemedics Corp's Net Margin
Over recent years, Psychemedics Corp's Net Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2023-12-31 | -18.80% |
| 2022-12-31 | -4.28% |
| 2021-12-31 | -2.69% |
| 2020-12-31 | -18.07% |
| 2019-12-31 | 4.09% |
This gradual decrease highlights how Psychemedics Corp manages its overall profitability and cost control over time.
Comparing Psychemedics Corp's Net Margin to Peers
To better understand Psychemedics Corp's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Psychemedics Corp (PMD) | -18.80% |
| Global Cord Blood Corp (CO) | 40.30% |
| Avem Health Partners Inc (FPCG) | 29.77% |
| PharmChem Inc (PCHM) | 22.69% |
| Interpace Biosciences Inc (IDXG) | 14.28% |
| Quest Diagnostics Inc (DGX) | 8.82% |
Compared to its competitors, Psychemedics Corp's Net Margin is about average compared to peers, reflecting typical industry profitability.